CONMED Corp (CNMD)
CONMED Corp (CNMD) from its SEC filings: 2025 revenue $1.4 billion (+5% vs the year before), net margin 3%, free cash flow $150.9 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Revenue (2025) | $1.4 billion |
| Revenue growth | +5% |
| Net income | $47.1 million |
| Net margin | 3.4% |
| Free cash flow | $150.9 million |
| Diluted EPS | $1.51 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +0% |
| Cash | $25.9 million |
| Long-term debt | $780.7 million |
| Share count, 1 year | -3% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.